Taejon, South Korea

Eu-Gene Oh


Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Eu-Gene Oh: Innovator in Therapeutic Compounds

Introduction

Eu-Gene Oh is a prominent inventor based in Taejon, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic compounds. With a total of 4 patents to his name, his work focuses on addressing critical medical issues.

Latest Patents

One of his latest patents involves dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses. These novel compounds are designed to treat and prevent various medical dysfunctions and diseases that arise from reactive oxygen species and excess zinc ions. Specifically, they target conditions such as stroke, Parkinson's disease, and Alzheimer's disease. The compounds exhibit low toxicity and demonstrate similar or superior lipid peroxidation (LPO) inhibition activity compared to existing references. Furthermore, they effectively inhibit cerebral neuronal cell death caused by reactive oxygen species and zinc ions, showcasing neuroprotective effects against ischemic neuronal degeneration.

Career Highlights

Eu-Gene Oh is currently associated with Samsung Electronics Co., Ltd., where he continues to innovate and develop therapeutic solutions. His work has garnered attention for its potential impact on treating neurodegenerative diseases.

Collaborations

He has collaborated with notable colleagues, including Sung-Bo Ko and Dennis W Choi, to advance his research and development efforts.

Conclusion

Eu-Gene Oh's contributions to the field of medicinal chemistry highlight his commitment to improving health outcomes through innovative therapeutic compounds. His work continues to pave the way for advancements in treating serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…